Vanguard Capital Management
RIGL icon

Vanguard Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Vanguard Capital Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.7M Buy
785,107
+20,914
+3% +$645K ﹤0.01% 2204
2026
Q1 		$20.7M Buy
+764,193
New +$25.7M ﹤0.01% 2326

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management's RIGL Position: Q2 2026 in Review

Vanguard Capital Management increased its Rigel Pharmaceuticals (RIGL) stake by 2.7% in Q2 2026, buying an estimated $645K and bringing the position to 785,107 shares worth $30.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2204.

Vanguard Capital Management first reported a position in RIGL in Q1 2026 and has held it in 2 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Vanguard Capital Management held 785,107 shares of Rigel Pharmaceuticals worth $30.7M as of Q2 2026.
  • Vanguard Capital Management bought 20,914 Rigel Pharmaceuticals shares in Q2 2026, an estimated $645K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2204 holding.
  • Vanguard Capital Management first reported a position in Rigel Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.